BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 12799369)

  • 21. Chromogranin A: a surprising link between granule biogenesis and hypertension.
    Kim T; Loh YP
    J Clin Invest; 2005 Jul; 115(7):1711-3. PubMed ID: 16007250
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mechanism of cardiovascular actions of the chromogranin A fragment catestatin in vivo.
    Kennedy BP; Mahata SK; O'Connor DT; Ziegler MG
    Peptides; 1998; 19(7):1241-8. PubMed ID: 9786174
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of novel loci affecting circulating chromogranins and related peptides.
    Benyamin B; Maihofer AX; Schork AJ; Hamilton BA; Rao F; Schmid-Schönbein GW; Zhang K; Mahata M; Stridsberg M; Schork NJ; Biswas N; Hook VY; Wei Z; Montgomery GW; Martin NG; Nievergelt CM; Whitfield JB; O'Connor DT
    Hum Mol Genet; 2017 Jan; 26(1):233-242. PubMed ID: 28011710
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Neurotrophin activation of catecholamine storage vesicle protein gene expression: signaling to chromogranin a biosynthesis.
    Mahata SK; Mahata M; Wu H; Parmer RJ; O'Connor DT
    Neuroscience; 1999 Jan; 88(2):405-24. PubMed ID: 10197763
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Distribution of catestatin-like immunoreactivity in the human auditory system.
    Bitsche M; Mahata SK; Marksteiner J; Schrott-Fischer A
    Hear Res; 2003 Oct; 184(1-2):16-26. PubMed ID: 14553900
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chromogranin B: intra- and extra-cellular mechanisms to regulate catecholamine storage and release, in catecholaminergic cells and organisms.
    Zhang K; Biswas N; Gayen JR; Miramontes-Gonzalez JP; Hightower CM; Mustapic M; Mahata M; Huang CT; Hook VY; Mahata SK; Vaingankar S; O'Connor DT
    J Neurochem; 2014 Apr; 129(1):48-59. PubMed ID: 24266713
    [TBL] [Abstract][Full Text] [Related]  

  • 27. New antimicrobial activity for the catecholamine release-inhibitory peptide from chromogranin A.
    Briolat J; Wu SD; Mahata SK; Gonthier B; Bagnard D; Chasserot-Golaz S; Helle KB; Aunis D; Metz-Boutigue MH
    Cell Mol Life Sci; 2005 Feb; 62(3):377-85. PubMed ID: 15723172
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Sympatho-adrenal secretion in humans: factors governing catecholamine and storage vesicle peptide co-release.
    Takiyyuddin MA; Brown MR; Dinh TQ; Cervenka JH; Braun SD; Parmer RJ; Kennedy B; O'Connor DT
    J Auton Pharmacol; 1994 Jun; 14(3):187-200. PubMed ID: 7929473
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Conformational preferences and activities of peptides from the catecholamine release-inhibitory (catestatin) region of chromogranin A.
    Preece NE; Nguyen M; Mahata M; Mahata SK; Mahapatra NR; Tsigelny I; O'Connor DT
    Regul Pept; 2004 Apr; 118(1-2):75-87. PubMed ID: 14759560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stimulus coupling to transcription versus secretion in pheochromocytoma cells. Convergent and divergent signal transduction pathways and the crucial roles for route of cytosolic calcium entry and protein kinase C.
    Tang K; Wu H; Mahata SK; Mahata M; Gill BM; Parmer RJ; O'Connor DT
    J Clin Invest; 1997 Sep; 100(5):1180-92. PubMed ID: 9276735
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Glucocorticoid activation of chromogranin A gene expression. Identification and characterization of a novel glucocorticoid response element.
    Rozansky DJ; Wu H; Tang K; Parmer RJ; O'Connor DT
    J Clin Invest; 1994 Dec; 94(6):2357-68. PubMed ID: 7989592
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Is physiologic sympathoadrenal catecholamine release exocytotic in humans?
    Takiyyuddin MA; Cervenka JH; Sullivan PA; Pandian MR; Parmer RJ; Barbosa JA; O'Connor DT
    Circulation; 1990 Jan; 81(1):185-95. PubMed ID: 2404624
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Heritability and genome-wide linkage in US and australian twins identify novel genomic regions controlling chromogranin a: implications for secretion and blood pressure.
    O'Connor DT; Zhu G; Rao F; Taupenot L; Fung MM; Das M; Mahata SK; Mahata M; Wang L; Zhang K; Greenwood TA; Shih PA; Cockburn MG; Ziegler MG; Stridsberg M; Martin NG; Whitfield JB
    Circulation; 2008 Jul; 118(3):247-57. PubMed ID: 18591442
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Processing of chromogranin A by plasmin provides a novel mechanism for regulating catecholamine secretion.
    Parmer RJ; Mahata M; Gong Y; Mahata SK; Jiang Q; O'Connor DT; Xi XP; Miles LA
    J Clin Invest; 2000 Oct; 106(7):907-15. PubMed ID: 11018079
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hypertension from targeted ablation of chromogranin A can be rescued by the human ortholog.
    Mahapatra NR; O'Connor DT; Vaingankar SM; Hikim AP; Mahata M; Ray S; Staite E; Wu H; Gu Y; Dalton N; Kennedy BP; Ziegler MG; Ross J; Mahata SK
    J Clin Invest; 2005 Jul; 115(7):1942-52. PubMed ID: 16007257
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neuroendocrine-specific and gastrin-dependent expression of a chromogranin A-luciferase fusion gene in transgenic mice.
    Höcker M; Cramer T; O'Connor DT; Rosewicz S; Wiedenmann B; Wang TC
    Gastroenterology; 2001 Jul; 121(1):43-55. PubMed ID: 11438493
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.
    O'Connor DT; Kailasam MT; Kennedy BP; Ziegler MG; Yanaihara N; Parmer RJ
    Ann N Y Acad Sci; 2002 Oct; 971():533-5. PubMed ID: 12438176
    [No Abstract]   [Full Text] [Related]  

  • 38. Chromogranin A deficiency in transgenic mice leads to aberrant chromaffin granule biogenesis.
    Kim T; Zhang CF; Sun Z; Wu H; Loh YP
    J Neurosci; 2005 Jul; 25(30):6958-61. PubMed ID: 16049171
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Catestatin, a neuroendocrine antimicrobial peptide, induces human mast cell migration, degranulation and production of cytokines and chemokines.
    Aung G; Niyonsaba F; Ushio H; Kajiwara N; Saito H; Ikeda S; Ogawa H; Okumura K
    Immunology; 2011 Apr; 132(4):527-39. PubMed ID: 21214543
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Proteolytic cleavage of chromogranin A (CgA) by plasmin. Selective liberation of a specific bioactive CgA fragment that regulates catecholamine release.
    Jiang Q; Taupenot L; Mahata SK; Mahata M; O'Connor DT; Miles LA; Parmer RJ
    J Biol Chem; 2001 Jul; 276(27):25022-9. PubMed ID: 11342539
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.